Determinants of different aspects of everyday outcome in schizophrenia: The roles of negative symptoms, cognition, and functional capacity - PubMed
Determinants of different aspects of everyday outcome in schizophrenia: The roles of negative symptoms, cognition, and functional capacity
Martin T Strassnig et al. Schizophr Res. 2015 Jun.
Abstract
Cognition, negative symptoms, and depression are potential predictors of disability in schizophrenia. We present analyses of pooled data from four separate studies (all n>169; total n=821) that assessed differential aspects of disability and their potential determinants. We hypothesized that negative symptoms would predict social outcomes, but not vocational functioning or everyday activities and that cognition and functional capacity would predict vocational functioning and everyday activities but not social outcomes. The samples were rated by clinician informants for their everyday functioning in domains of social and vocational outcomes, and everyday activities, examined with assessments of cognition and functional capacity, rated clinically with the Positive and Negative Syndrome Scale (PANSS) and self-reporting depression. We computed a model that tested the hypotheses described above and compared it to a model that predicted that negative symptoms, depression, cognition, and functional capacity had equivalent influences on all aspects of everyday functioning. The former, specific relationship model fit the data adequately and we subsequently confirmed a similar fit within all four samples. Analyses of the relative goodness of fit suggested that this specific model fit the data better than the more general, equivalent influence predictor model. We suggest that treatments aimed at cognition may not affect social functioning as much as other aspects of disability, a finding consistent with earlier research on the treatment of cognitive deficits in schizophrenia, while negative symptoms predicted social functioning. These relationships are central features of schizophrenia and treatment efforts should be aimed accordingly.
Keywords: Cognition; Functional capacity; Negative symptoms; Schizophrenia; Social functioning.
Copyright © 2015 Elsevier B.V. All rights reserved.
Figures
Similar articles
-
Leifker FR, Bowie CR, Harvey PD. Leifker FR, et al. Schizophr Res. 2009 Nov;115(1):82-7. doi: 10.1016/j.schres.2009.09.004. Epub 2009 Sep 22. Schizophr Res. 2009. PMID: 19775869
-
Vesterager L, Christensen TØ, Olsen BB, Krarup G, Melau M, Forchhammer HB, Nordentoft M. Vesterager L, et al. Schizophr Res. 2012 Nov;141(2-3):251-6. doi: 10.1016/j.schres.2012.08.023. Epub 2012 Sep 25. Schizophr Res. 2012. PMID: 23017825 Clinical Trial.
-
Strassnig M, Bowie C, Pinkham AE, Penn D, Twamley EW, Patterson TL, Harvey PD. Strassnig M, et al. J Psychiatr Res. 2018 Sep;104:124-129. doi: 10.1016/j.jpsychires.2018.06.018. Epub 2018 Jul 7. J Psychiatr Res. 2018. PMID: 30029051
-
Harvey PD. Harvey PD. Schizophr Res. 2013 Nov;150(2-3):353-5. doi: 10.1016/j.schres.2013.04.022. Epub 2013 May 11. Schizophr Res. 2013. PMID: 23668973 Free PMC article. Review.
-
Functional capacity: a new framework for the assessment of everyday functioning in schizophrenia.
Mantovani LM, Teixeira AL, Salgado JV. Mantovani LM, et al. Braz J Psychiatry. 2015 Jul-Sep;37(3):249-55. doi: 10.1590/1516-4446-2014-1551. Braz J Psychiatry. 2015. PMID: 26376057 Review.
Cited by
-
Cell-based therapies for the treatment of schizophrenia.
Donegan JJ, Lodge DJ. Donegan JJ, et al. Brain Res. 2017 Jan 15;1655:262-269. doi: 10.1016/j.brainres.2016.08.010. Epub 2016 Aug 18. Brain Res. 2017. PMID: 27544423 Free PMC article. Review.
-
Harvey PD, Deckler E, Jarskog F, Penn DL, Pinkham AE. Harvey PD, et al. Schizophr Res. 2019 Apr;206:271-276. doi: 10.1016/j.schres.2018.11.005. Epub 2018 Nov 13. Schizophr Res. 2019. PMID: 30446271 Free PMC article.
-
Basavaraju R, Ithal D, Thanki MV, Ramalingaiah AH, Thirthalli J, Reddy RP, Brady RO Jr, Halko MA, Bolo NR, Keshavan MS, Pascual-Leone A, Mehta UM, Kesavan M. Basavaraju R, et al. Schizophr Res. 2021 Dec;238:108-120. doi: 10.1016/j.schres.2021.10.005. Epub 2021 Oct 12. Schizophr Res. 2021. PMID: 34653740 Free PMC article. Clinical Trial.
-
Association of Cognitive Impairment With Anhedonia in Patients With Schizophrenia.
Yu L, Ni H, Wu Z, Fang X, Chen Y, Wang D, Zhang C. Yu L, et al. Front Psychiatry. 2021 Dec 2;12:762216. doi: 10.3389/fpsyt.2021.762216. eCollection 2021. Front Psychiatry. 2021. PMID: 34925093 Free PMC article.
-
Strassnig MT, Harvey PD, Miller ML, Depp CA, Granholm E. Strassnig MT, et al. Ment Health Phys Act. 2021 Mar;20:10.1016/j.mhpa.2020.100364. doi: 10.1016/j.mhpa.2020.100364. Ment Health Phys Act. 2021. PMID: 34221125 Free PMC article.
References
-
- Andreasen NC, Flaum M, Arndt S. The comprehensive assessment of symptoms and history (CASH): An instrument for assessing psychopathology and diagnosis. Arch Gen Psychiatry. 1992;49:615–623. - PubMed
-
- Beck AT, Steer RA, Brown GK. Manual. 2. San Antonio, Tex: Psychological Corp; 1996. Beck Depression Inventory.
-
- Bollen KA. Structural equations with latent variables. New York: Wiley; 1989.
-
- Bowie CR, McGurk SM, Mausbach BT, Patterson TL, Harvey PD. Combined cognitive remediation and functional skills training for Schizophrenia: Effects on Cognition, Functional Competence, and Real-world behavior. Am J Psychiatry. 2012;169:710–718. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical